Aimei Health Technology Co., Ltd. 8-K

What Happened
Aimei Health Technology Co., Ltd. announced a one‑month extension of its SPAC termination date from April 6, 2026 to May 6, 2026 by depositing $34,330.96 (the “Extension Payment”) into its public shareholders’ trust account. To fund that payment, on April 7, 2026 the company issued an unsecured promissory note for $34,330.96 to Aimei Health Ltd (the Sponsor) and United Hydrogen Group Inc. (each a “Payee”).

Key Details

• Extension: one‑month extension of the Termination Date, from April 6, 2026 to May 6, 2026; this is the seventeenth extension permitted under the company’s Amended and Restated Articles of Association.
• Extension Payment: $34,330.96 deposited into the trust account (represents the lesser of $80,000 total or $0.033 per outstanding public share per month).
• Promissory Note: issued April 7, 2026 for $34,330.96 (no interest), funded equally by the Sponsor and United Hydrogen ($17,165.48 each); unsecured and payable when the company consummates a business combination with United Hydrogen.
• Conversion right: the Payees may, but are not required to, convert all or part of the note into private units at $10.00 per unit (one ordinary share plus a right to receive 1/5 of an ordinary share) if they notify the company at least two business days before closing of the business combination.

Why It Matters
The filing documents a short-term funding step that allows Aimei Health more time to close a business combination (now due May 6, 2026). The promissory note creates a contractual obligation that is non‑interest bearing and becomes payable upon closing; it also includes a conversion option that could result in issuance of private units to the Sponsor and United Hydrogen. Investors should note the extension was funded by related parties and the note’s terms (unsecured, payable at closing, convertible at $10/unit), which are relevant to the company’s post‑combination capital structure and obligations.